Product Information
Name:Dilpacimab
Synonyms:
- PR1283233
- PR 1283233
- ABT-165
- ABT165
Brand:Targetmol
Description:Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Purity:95% - 95%
Color/Form:Liquid
Technical inquiry about: Dilpacimab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.